glp 1 how do you take it to Use GLP-1 Medication Safely GLP-1 Medications: Everything You Need

Liu H, Wang G, Zhang J, Lu B, Li D, Chen J

How Soon Will You See Results

GLP-1 drug penetration below 4% of eligible patients Top GLP-1 market: United States with 62.8% of global GLP-1 weight loss drug revenue Cardiovascular approval catalyst: Wegovy approved for MACE risk reduction following SELECT trial demonstrating 20% reduction in major adverse cardiovascular events Fastest-growing indication: Obstructive sleep apnea at 41.2% CAGR following Zepbound FDA approval November 2025 Market Overview: Why GLP-1 Weight Loss Drug Market Growth Is Accelerating The GLP-1 Weight Loss Drug Market is at an unprecedented commercial inflection point defined by three simultaneous demand accelerators

Norris, K

Retatrutide and other newer GLP-1 agonists: no lactation data yet The GLP-1 landscape is expanding rapidly